Spectra Systems Corporation
("The Company" or "Spectra")
Annual General Meeting Lack of Quorum
Spectra (AIM: SPSY.L) announces that, having received only 9 ballots, it does not have enough shareholder votes to achieve a quorum to transact business at its scheduled 2022 Annual General Meeting on 13 June 2022. The presence in person or by proxy, duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote constitutes a quorum.
A summary of the votes received is as follows:
| Resolution | For | Against | Discretion | Withheld | Total |
| Elect BJ Penn as Director | 12,345,133 | - | - | 6,441,048 | 18,786,181 |
| Elect Nabil Lawandy as Director | 17,431,307 | - | - | 1,354,874 | 18,786,181 |
| Elect Jeremy Fry as Director | 17,431,307 | - | - | 1,354,874 | 18,786,181 |
| Elect Donald Stanford as Director | 12,345,133 | - | - | 6,441,048 | 18,786,181 |
| Ratification of Appointment of Independent Auditor | 17,431,307 | 1,354,874 | - | - | 18,786,181 |
Total shares of stock outstanding as of the record date of 10 June, 2022 was 45,320,439. Therefore, only approximately 41% of the shares of stock were voted.
Enquiries:
Spectra Systems Corporation
Dr. Nabil Lawandy (Chief Executive Officer) Tel: +1 (0) 401 274 4700
| WH Ireland Limited (Nominated Adviser and Broker) Chris Fielding (Managing Director, Corporate Finance) Andrew de Andrade (Executive, Corporate Finance)
Allenby Capital Limited (Joint Broker) Nick Naylor/James Reeve (Corporate Finance) Amrit Nahal (Sales and Corporate Broking) | Tel: +44 (0)20 7220 1650
Tel: +44 (0)20 3328 5665
|
The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.